| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $61.1M | +20.6% |
| SG&A Expense | $27.0M | +9.4% |
| Operating Income | -$87.6M | -2.9% |
| Interest Expense | $4.0M | +9.6% |
| Pre-tax Income | -$93.8M | -5.8% |
| Income Tax | $28K | +64.7% |
| Net Income | -$93.9M | -5.8% |
| EPS (Basic) | -$1.52 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.7M | +48.8% |
| Current Assets | $128.7M | +46.4% |
| Total Assets | $155.6M | +32.8% |
| Current Liabilities | $22.3M | +59.2% |
| Long-term Debt | $32.5M | +0.0% |
| Total Liabilities | $81.5M | +54.5% |
| Stockholders' Equity | $74.1M | +15.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.1M | -8.7% |
| Investing Cash Flow | -$103K | +83.3% |
| Financing Cash Flow | $117.2M | +57.9% |
| +61.9% |
| EPS (Diluted) | -$1.52 | +61.9% |